What Is the Interpretation of the Following Patient Results? (Normal

question 1

Multiple Choice

What is the interpretation of the following patient results? (normal values) WBC = 90.0 th/uL (5.0-10.0 th/uL,) ,with 89% lymphs (20-40%) ; CD3 = 90% (60-80%) ; CD5 = 87% (60-80%) ; CD10 = 0% (< 1%) ; CD4 = 88% (30-65%) ; CD20 = 12% (5-20%) ; CD34 = 0% (< 1%) ; CD8 = 3% (10-40%) ; kappa = 10% (3-15%) ; lambda = 5% (2-10%) ; CD19 = 15% (5-20%) .

• A) normal
• B) B-cell acute leukemia
• C) T-cell acute leukemia
• D) B-cell chronic leukemia
• E) T-cell chronic leukemia

---

Definitions:

Product Diversity

The range and variety of products and services offered by firms within a market or industry.

Competitive Market

A market structure characterized by a large number of buyers and sellers, free entry and exit, and products that are similar across suppliers, ensuring no single entity can control prices.

Entry Barriers

Obstacles that make it difficult for new competitors to enter an industry or market.

Regulatory Standards

Specifications and guidelines established by authorities designed to ensure products, services, and actions meet required safety, quality, and performance criteria.